• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆三甲胺 N-氧化物水平升高与糖尿病视网膜病变有关。

Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy.

机构信息

Department of Ophthalmology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, People's Republic of China.

Suzhou Center for Disease Control and Prevention, 72 Sanxiang Road, Suzhou, 215004, People's Republic of China.

出版信息

Acta Diabetol. 2021 Feb;58(2):221-229. doi: 10.1007/s00592-020-01610-9. Epub 2020 Oct 16.

DOI:10.1007/s00592-020-01610-9
PMID:33064205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7889550/
Abstract

AIMS

To determine the relationship between plasma levels of trimethylamine-N-oxide (TMAO) and odds of diabetic retinopathy (DR).

METHODS

A cross-sectional study was conducted. Blood samples were obtained from 122 type 2 diabetes mellitus (T2DM) patients with or without DR. Multivariable logistic regression analyses were performed to identify the association between plasma TMAO and DR. The diagnostic value of plasma TMAO was assessed by the area under the receiver operating characteristic curve (AUROC) and integrated discrimination improvement (IDI).

RESULTS

In the T2DM patients, plasma levels of TMAO were significantly higher in patients with DR compared with those without DR (P = 0.001). As logarithmic (ln) transformation of TMAO increased per standard deviation (SD), there was higher probability to have DR [odds ratio (OR) = 2.31; P = 0.005]. As ln-transformed TMAO increased per SD, the severity of DR was more likely to get worse (OR = 2.05; P = 0.004). In the diagnostic model, the addition of TMAO contributed to the improvement in AUROC from 0.646 to 0.734 (P = 0.043), and the IDI was 10.7% (P < 0.001).

CONCLUSION

Elevated levels of plasma TMAO were associated with higher odds and worse severity of DR in T2DM patients, and further investigation is required for the causality of this association.

摘要

目的

确定血浆中三甲胺 N-氧化物(TMAO)水平与糖尿病视网膜病变(DR)发生几率之间的关系。

方法

进行了一项横断面研究。从 122 名 2 型糖尿病(T2DM)患者中采集血液样本,这些患者患有或不患有 DR。采用多变量逻辑回归分析来确定血浆 TMAO 与 DR 之间的关联。通过接受者操作特征曲线(AUROC)下面积和综合判别改善(IDI)评估血浆 TMAO 的诊断价值。

结果

在 T2DM 患者中,患有 DR 的患者的血浆 TMAO 水平明显高于没有 DR 的患者(P=0.001)。当 TMAO 对数(ln)转换值每增加一个标准差(SD)时,发生 DR 的可能性就会更高[比值比(OR)=2.31;P=0.005]。当 ln 转换的 TMAO 每增加一个 SD 时,DR 的严重程度更有可能恶化(OR=2.05;P=0.004)。在诊断模型中,添加 TMAO 可使 AUROC 从 0.646 提高到 0.734(P=0.043),IDI 为 10.7%(P<0.001)。

结论

血浆 TMAO 水平升高与 T2DM 患者发生 DR 的几率和严重程度增加有关,需要进一步研究这种关联的因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1521/7889550/247ad69addf4/592_2020_1610_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1521/7889550/03f80c3af6f6/592_2020_1610_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1521/7889550/247ad69addf4/592_2020_1610_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1521/7889550/03f80c3af6f6/592_2020_1610_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1521/7889550/247ad69addf4/592_2020_1610_Fig2_HTML.jpg

相似文献

1
Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy.血浆三甲胺 N-氧化物水平升高与糖尿病视网膜病变有关。
Acta Diabetol. 2021 Feb;58(2):221-229. doi: 10.1007/s00592-020-01610-9. Epub 2020 Oct 16.
2
Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.肠道微生物生成的代谢产物三甲胺 N-氧化物与糖尿病风险:系统评价和剂量反应荟萃分析。
Obes Rev. 2019 Jun;20(6):883-894. doi: 10.1111/obr.12843. Epub 2019 Mar 13.
3
Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention.肠道微生物衍生代谢物三甲胺 N-氧化物的动态变化与 2 型糖尿病风险:饮食改变在糖尿病预防中的潜力。
Nutrients. 2024 May 30;16(11):1711. doi: 10.3390/nu16111711.
4
The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus.血浆三甲胺氧化物水平与中国 2 型糖尿病或非 2 型糖尿病患者冠心病风险的关系。
Dis Markers. 2018 Aug 8;2018:1578320. doi: 10.1155/2018/1578320. eCollection 2018.
5
Association between microbiota-dependent metabolite trimethylamine--oxide and type 2 diabetes.微生物群依赖的代谢产物氧化三甲胺与2型糖尿病之间的关联。
Am J Clin Nutr. 2017 Sep;106(3):888-894. doi: 10.3945/ajcn.117.157107. Epub 2017 Jul 19.
6
Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.血浆中三甲胺 N-氧化物及相关代谢物与 2 型糖尿病发病风险的相关性:心血管健康研究。
JAMA Netw Open. 2021 Aug 2;4(8):e2122844. doi: 10.1001/jamanetworkopen.2021.22844.
7
Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.血浆中miR-93的水平与发生2型糖尿病视网膜病变的较高风险相关。
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1159-1166. doi: 10.1007/s00417-017-3638-5. Epub 2017 Apr 5.
8
Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.肠道微生物代谢产物 TMAO 预示急性缺血性脑卒中的预后。
J Neuroimmunol. 2021 May 15;354:577526. doi: 10.1016/j.jneuroim.2021.577526. Epub 2021 Feb 20.
9
Association of serum trimethylamine N-oxide levels and bone mineral density in type 2 diabetes mellitus.血清三甲胺 N-氧化物水平与 2 型糖尿病患者骨密度的相关性研究。
Endocrine. 2024 Jun;84(3):958-968. doi: 10.1007/s12020-024-03699-2. Epub 2024 Jan 29.
10
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.在2型糖尿病患者中,三甲胺N-氧化物水平升高预示着高死亡风险,且独立于血糖控制情况。
Clin Chem. 2017 Jan;63(1):297-306. doi: 10.1373/clinchem.2016.263640. Epub 2016 Nov 18.

引用本文的文献

1
Evaluation of prothymosin alpha, trimethylamine-N-oxide, and ischemia-modified albumin in type 2 diabetes mellitus patients with dysregulated lipid profile.对脂质谱紊乱的2型糖尿病患者中前胸腺素α、氧化三甲胺和缺血修饰白蛋白的评估。
Qatar Med J. 2025 Jun 11;2025(2):39. doi: 10.5339/qmj.2025.39. eCollection 2025.
2
Gut-associated metabolites and diabetes pathology: a systematic review.肠道相关代谢产物与糖尿病病理:一项系统综述
Front Endocrinol (Lausanne). 2025 May 21;16:1559638. doi: 10.3389/fendo.2025.1559638. eCollection 2025.
3
TMAO and diabetes: from the gut feeling to the heart of the problem.

本文引用的文献

1
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.血浆三甲胺 N-氧化物与 2 型糖尿病患者心血管事件风险。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa188.
2
Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.血浆三甲胺 N-氧化物、胆碱、肉碱和甜菜碱与炎症和心血管代谢风险生物标志物及多民族队列肥胖表型研究中粪便微生物组的相关性。
Am J Clin Nutr. 2020 Jun 1;111(6):1226-1234. doi: 10.1093/ajcn/nqaa015.
3
氧化三甲胺与糖尿病:从直觉到问题的核心
Nutr Diabetes. 2025 May 20;15(1):21. doi: 10.1038/s41387-025-00377-8.
4
Research progress of gut microbiome and diabetic nephropathy.肠道微生物群与糖尿病肾病的研究进展
Front Med (Lausanne). 2024 Dec 13;11:1490314. doi: 10.3389/fmed.2024.1490314. eCollection 2024.
5
Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke.肠道微生物衍生代谢物三甲胺 N-氧化物与缺血性脑卒中。
Biomolecules. 2024 Nov 18;14(11):1463. doi: 10.3390/biom14111463.
6
Explainable machine learning model for predicting the risk of significant liver fibrosis in patients with diabetic retinopathy.用于预测糖尿病视网膜病变患者发生显著肝纤维化风险的可解释机器学习模型。
BMC Med Inform Decis Mak. 2024 Nov 11;24(1):332. doi: 10.1186/s12911-024-02749-z.
7
The human gut microbiome in health and disease: time for a new chapter?人类肠道微生物组与健康和疾病:新篇章的开始?
Infect Immun. 2024 Nov 12;92(11):e0030224. doi: 10.1128/iai.00302-24. Epub 2024 Sep 30.
8
Research progress on the mechanism of TCM regulating intestinal microbiota in the treatment of DM mellitus.中医调节肠道微生物群治疗糖尿病机制的研究进展。
Front Endocrinol (Lausanne). 2024 Mar 27;15:1308016. doi: 10.3389/fendo.2024.1308016. eCollection 2024.
9
Trimethylamine N-oxide aggravates vascular permeability and endothelial cell dysfunction under diabetic condition: and study.在糖尿病状态下,氧化三甲胺会加重血管通透性和内皮细胞功能障碍:一项研究。
Int J Ophthalmol. 2024 Jan 18;17(1):25-33. doi: 10.18240/ijo.2024.01.04. eCollection 2024.
10
Gut dysbiosis: Ecological causes and causative effects on human disease.肠道菌群失调:生态原因及其对人类疾病的因果影响。
Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2316579120. doi: 10.1073/pnas.2316579120. Epub 2023 Dec 4.
Diabetic Retinopathy Preferred Practice Pattern®.
糖尿病视网膜病变首选诊疗模式®
Ophthalmology. 2020 Jan;127(1):P66-P145. doi: 10.1016/j.ophtha.2019.09.025. Epub 2019 Sep 25.
4
High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction.高迁移率族蛋白 B1 介导 TMAO 诱导的内皮功能障碍。
Int J Mol Sci. 2019 Jul 22;20(14):3570. doi: 10.3390/ijms20143570.
5
Sex, gut microbiome, and cardiovascular disease risk.性别、肠道微生物组与心血管疾病风险。
Biol Sex Differ. 2019 Jun 10;10(1):29. doi: 10.1186/s13293-019-0240-z.
6
Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.血浆氧化三甲胺浓度在预测 1 型糖尿病个体心血管和肾脏并发症中的作用。
Diabetes Care. 2019 Aug;42(8):1512-1520. doi: 10.2337/dc19-0048. Epub 2019 May 23.
7
Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief Report.黄素单加氧酶 3(Fmo3)基因缺失可预防血栓形成,但对血浆脂质水平影响较小——简短报告。
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1045-1054. doi: 10.1161/ATVBAHA.119.312592.
8
Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.肠道微生物生成的代谢产物三甲胺 N-氧化物与糖尿病风险:系统评价和剂量反应荟萃分析。
Obes Rev. 2019 Jun;20(6):883-894. doi: 10.1111/obr.12843. Epub 2019 Mar 13.
9
Trimethylamine N-oxide, Mediterranean diet, and nutrition in healthy, normal-weight adults: also a matter of sex?三甲胺 N-氧化物、地中海饮食与健康、正常体重成年人的营养:性别也是一个因素?
Nutrition. 2019 Jun;62:7-17. doi: 10.1016/j.nut.2018.11.015. Epub 2018 Nov 24.
10
Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects.比较伴有和不伴有视网膜病变的糖尿病患者粪便样本与对照受试者的肠道厌氧菌(拟杆菌门)的筛选和鉴定。
Microb Pathog. 2019 Apr;129:88-92. doi: 10.1016/j.micpath.2019.01.025. Epub 2019 Jan 29.